Article

Geriatric assessment in elderly patients with prostate cancer.

Geriatric Oncology Program, Centre Leon Berard, Lyon, France.
Clinical prostate cancer 04/2004; 2(4):236-40. pp.236-40
Source: PubMed

ABSTRACT As a result of demographic evolution, oncologists will treat more and more elderly patients with prostate cancer. Aging is frequently associated with the coexistence of several medical complications that can increase the complexity of cancer treatment decision-making. Unfortunately, clinical oncologists need to be more familiar with the multidimensional assessment of elderly patients. To acquire this skill, we implemented a multidimensional geriatric assessment program at our cancer center. This instrument prospectively assessed 60 elderly patients with prostate cancer. Herein, we describe geriatric aspects detected in our patient sample and report treatment options proposed to elderly patients with prostate cancer at different disease stages. The minimal comprehensive geriatric assessment (mini-CGA) procedure revealed that 66% of our patient population was dependent in one or more of the Katz Activities of Daily Living and 87% were dependent in 1 or more of the Lawton Instrumental Activities of Daily Living; all patients had significant comorbidity according to the Cumulative Illness Rating Scale-Geriatrics, 75% having at least one severe comorbidity. We identified 19 cases of drug interaction. We also observed that half of these patients had a risk of falling and some physical disability; 45% had cognitive disorders requiring more investigation; one third had depressive symptoms. Finally, 65% of the patients were either malnourished or at risk of malnutrition. Many of these problems were unknown before the mini-CGA processing and may interfere with cancer and cancer treatment. Thus, the correct management of elderly patients with cancer requires comprehensive geriatric assessment as well as relevant disease staging at diagnosis. This approach will help us to propose the most appropriate treatment with the main aim of preserving quality of life.

0 0
 · 
0 Bookmarks
 · 
28 Views
  • Source
    Article: Use of Geriatric Assessment for Older Adults in the Oncology Setting: A Systematic Review
    JNCI Journal of the National Cancer Institute 07/2012; · 13.76 Impact Factor
  • Source
    Article: Use of geriatric assessment for older adults in the oncology setting: a systematic review.
    [show abstract] [hide abstract]
    ABSTRACT: Geriatric assessment is a multidisciplinary diagnostic process that evaluates the older adult's medical, psychological, social, and functional capacity. No systematic review of the use of geriatric assessment in oncology has been conducted. The goals of this systematic review were: 1) to provide an overview of all geriatric assessment instruments used in the oncology setting; 2) to examine the feasibility and psychometric properties of those instruments; and 3) to systematically evaluate the effectiveness of geriatric assessment in predicting or modifying outcomes (including the impact on treatment decision making, toxicity of treatment, and mortality). We searched Medline, Embase, Psychinfo, Cinahl, and the Cochrane Library for articles published in English, French, Dutch, or German between January 1, 1996, and November 16, 2010, reporting on cross-sectional, longitudinal, interventional, or observational studies that assessed the feasibility or effectiveness of geriatric assessment instruments. The quality of articles was evaluated using relevant quality assessment frameworks. We identified 83 articles that reported on 73 studies. The quality of most studies was poor to moderate. Eleven studies examined psychometric properties or diagnostic accuracy of the geriatric assessment instruments used. The assessment generally took 10-45 min. Geriatric assessment was most often completed to describe a patient's health and functional status. Specific domains of geriatric assessment were associated with treatment toxicity in 6 of 9 studies and with mortality in 8 of 16 studies. Of the four studies that examined the impact of geriatric assessment on the cancer treatment decision, two found that geriatric assessment impacted 40%-50% of treatment decisions. Geriatric assessment in the oncology setting is feasible, and some domains are associated with adverse outcomes. However, there is limited evidence that geriatric assessment impacted treatment decision making. Further research examining the effectiveness of geriatric assessment on treatment decisions and outcomes is needed.
    CancerSpectrum Knowledge Environment 07/2012; 104(15):1133-63. · 14.07 Impact Factor
  • Article: Assessment of older patients in oncology
    [show abstract] [hide abstract]
    ABSTRACT: Cancer is a disease of the elderly with almost 60% of new cancer diagnoses and 70% of cancer deaths occurring in patients over 65 years of age. With population ageing the prevalence of cancer in older patients is expected to rise even further in the future. Choosing the optimal treatment for older cancer patients is challenging since ageing is often related with physiological changes and organ function impairment that can alter anticancer treatment tolerance and efficacy. Ageing is a highly individualized process and chronological age alone cannot accurately define the functional reserve and life expectancy of an individual. A number of methods have been developed for a thorough assessment of older patients in order to help treatment decisions. The comprehensive geriatric assessment of older patients in oncology is presented in this article.
    Forum of Clinical Oncology. 03/2012; 2:41-47.

Keywords

60 elderly patients
 
appropriate treatment
 
cancer center
 
cancer treatment
 
cancer treatment decision-making
 
clinical oncologists
 
comprehensive geriatric assessment
 
Cumulative Illness Rating Scale-Geriatrics
 
demographic evolution
 
different disease stages
 
drug interaction
 
elderly patients
 
Lawton Instrumental Activities
 
main aim
 
medical complications
 
minimal comprehensive geriatric assessment
 
multidimensional geriatric assessment program
 
one severe comorbidity
 
patient sample
 
report treatment options